Andrew Moreo and Lenore Giannunzio of Andelyn Biosciences, discuss some of the ongoing challenges in viral vector manufacturing, including optimizing yields, tech transfer, and the supply chain, and how Andelyn's unique experience and expertise can ensure program success.
.svg)
